Skip to content

Author

Adir Alper

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Abstract 4219: Baxdrostat in Resistant and Uncontrolled Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Aldosterone dysregulation is becoming more widely acknowledged as a key factor in resistant hypertension. Baxdrostat, a highly selective aldosterone synthase inhibitor that shows a 100:1 preference for CYP11B2 over CYP11B1, has been tested in various randomized controlled trials involving different hyper...

Adir Alper, M. Lerner, A. Karthikeyan et al. · 0 citations
Nov 2026

Abstract 7621: Discontinuation of Oral Anticoagulation After Successful Atrial Fibrillation Ablation: A Meta-Analysis of Randomized Controlled Trials

Background: The optimal strategy for long-term oral anticoagulation (OAC) after catheter ablation for atrial fibrillation (AF) remains uncertain. Although current guidelines recommend anticoagulation based on thromboembolic risk scores irrespective of rhythm status, this recommendation has not been validated by rand...

A. Karthikeyan, Maisha Maliha, Adir Alper et al. · 0 citations
Review Open access Sep 2026

Cardiometabolic outcomes of once-weekly IcoSema in adults with type 2 diabetes: systematic review and meta-analysis of the COMBINE trials

Once-weekly IcoSema delivers meaningful improvements in weight, blood pressure, and atherogenic lipids, all key modifiable drivers of ASCVD in adults with type 2 diabetes and suggests potential for enhanced ASCVD prevention and improved long-term adherence.

Adir Alper, Adina Fagin, A. Karthikeyan et al. · 1 citation
Open access Sep 2026

Bilateral pulmonary embolism in anti-NMDA receptor encephalitis presenting as acute psychosis.

This case underscores the importance of considering autoimmune encephalitis in young patients presenting with new-onset psychosis, in the apparent absence of malignancy, and a high index of suspicion and early CSF evaluation can prevent diagnostic delay and improve patient outcomes.

Natali Sorajja, Adir Alper, Luca Biavati et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.